CIBC Bancorp USA’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.84M Sell
54,916
-9,151
-14% -$783K 0.01% 761
2026
Q2
$4.94M Sell
64,067
-20,306
-24% -$1.48M 0.01% 757
2026
Q1
$5.51M Buy
+84,373
New +$6.27M 0.01% 677
2025
Q3
$1.51M Buy
+20,631
New +$1.51M 0.01% 632

Other funds holding SOLV

CIBC Bancorp USA's SOLV Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Solventum (SOLV) stake by 14% in Q3 2026, selling an estimated $783K and leaving 54,916 shares worth $4.84M. The position accounts for 0.01% of the portfolio, ranked #761.

CIBC Bancorp USA first reported a position in SOLV in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.51M in Q1 2026. 891 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • CIBC Bancorp USA held 54,916 shares of Solventum worth $4.84M as of Q3 2026.
  • CIBC Bancorp USA sold 9,151 Solventum shares in Q3 2026, an estimated $783K.
  • Solventum made up 0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #761 holding.
  • CIBC Bancorp USA first reported a position in Solventum in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Solventum position peaked at $5.51M in Q1 2026.
  • 891 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.